研究者詳細 - 粕谷　英樹

論文 - 粕谷　英樹

分割表示 72 件中 1 - 20 件目／全件表示 >>

STING activator 2′3′-cGAMP enhanced HSV-1-based oncolytic viral therapy

Sibal, PA; Matsumura, S; Ichinose, T; Bustos-Villalobos, I; Morimoto, D; Eissa, IR; Abdelmoneim, M; Aboalela, MAM; Mukoyama, N; Tanaka, M; Naoe, Y; Kasuya, H

MOLECULAR ONCOLOGY 18 巻 ( 5 ) 頁： 1259 - 1277 2024年5月

The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies

Abdelmoneim, M; Aboalela, MA; Naoe, Y; Matsumura, S; Eissa, IR; Bustos-Villalobos, I; Sibal, PA; Takido, Y; Kodera, Y; Kasuya, H

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 巻 ( 17 ) 2023年9月

Novel new cell therapy of chimeric antigen receptors into dendritic cells

Naoe, Y; Abdelmoneim, MA; Aboalela, M; Eissa, IR; Matsumura, S; Kasuya, H

CANCER SCIENCE 114 巻頁： 997 - 997 2023年2月

Expression of CAR Targets on Solid Tumors by Armed Oncolytic virus has synergetic effect on CAR-T cell therapy

Aboalela, MA; Abdelmoneim, MA; Naoe, Y; Matsumura, S; Kasuya, H

CANCER SCIENCE 114 巻頁： 994 - 994 2023年2月

Expression of CAR Targets on Solid Tumors by Armed Oncolytic virus has synergetic effect on CAR-T cell therapy

Aboalela, MA; Abdelmoneim, MA; Naoe, Y; Matsumura, S; Kasuya, H

CANCER SCIENCE 114 巻頁： 1419 - 1419 2023年2月

Novel armed oncolytic HSV exhibits strong antitumor effects that lead to complete tumor regression

Abdelmoneim, MA; Naoe, Y; Eissa, IR; Aboalela, MA; Matsumura, S; Tanaka, M; Kasuya, H

CANCER SCIENCE 114 巻頁： 1855 - 1855 2023年2月

Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model

Abdelmoneim, M; Eissa, IR; Aboalela, MA; Naoe, Y; Matsumura, S; Sibal, PA; Bustos-Villalobos, I; Tanaka, M; Kodera, Y; Kasuya, H

SCIENTIFIC REPORTS 12 巻 ( 1 ) 頁： 21570 2022年12月

An international medical education perspective on training in child and adolescent psychiatry

Aleksic, B; Kasuya, H

ASIA-PACIFIC PSYCHIATRY 14 巻 ( 2 ) 頁： e12509 2022年6月

Oncolytic HSV HF10 (canerpaturev, C-REV) promotes accumulation of CD8+PD-1-tumor-infiltrating T cells in a SCC model

Mohamed, AA; Eissa, IR; Mukoyama, N; Abdelmoneim, M; Naoe, Y; Matsumura, S; Bustosvillalobos, I; Ichinose, T; Miyajima, N; Morimoto, D; Tanaka, M; Fujimoto, Y; Sone, M; Kodera, Y; Kasuya, H

CANCER SCIENCE 113 巻頁： 526 - 526 2022年2月

S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model

Miyajima, N; Eissa, IR; Abdelmoneim, M; Naoe, Y; Ichinose, T; Matsumura, S; Bustos-Villalobos, I; Mukoyama, N; Morimoto, D; Shibata, M; Takeuchi, D; Tsunoda, N; Kikumori, T; Tanaka, M; Kodera, Y; Kasuya, H

NAGOYA JOURNAL OF MEDICAL SCIENCE 83 巻 ( 4 ) 頁： 683 - 696 2021年11月

Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8<SUP>+</SUP>PD-1<SUP>-</SUP> tumor-infiltrating T cells in PD-L1-enriched tumor microenvironment

Eissa, IR; Mukoyama, N; Abdelmoneim, M; Naoe, Y; Matsumura, S; Bustos-Villalobos, I; Ichinose, T; Miyajima, N; Morimoto, D; Tanaka, M; Fujimoto, Y; Sone, M; Kodera, Y; Kasuya, H

INTERNATIONAL JOURNAL OF CANCER 149 巻 ( 1 ) 頁： 214 - 227 2021年7月

C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells

Morimoto, D; Matsumura, S; Bustos-Villalobos, I; Sibal, PA; Ichinose, T; Naoe, Y; Eissa, IR; Abdelmoneim, M; Mukoyama, N; Miyajima, N; Tanaka, M; Kodera, Y; Kasuya, H

CELLS 10 巻 ( 6 ) 2021年6月

Problem-Based Learning in Child and Adolescent Psychiatry: A Perspective from Japan

Iwatsuki, J; Kondo, T; Takahashi, N; Takami, H; Nishigori, H; Bustos-Villalobos, I; Aleksic, B; Kasuya, H; Ban, NO; Yagi, T; Skokauskas, N

ADVANCES IN MEDICAL EDUCATION AND PRACTICE 12 巻頁： 1329 - 1335 2021年

Continuing medical education during pandemic waves of COVID-19: Consensus from medical faculties in Asia, Australia and Europe.

Wong C, van den Broek W, Doody G, Fischer M, Leech M, De Ponti F, Gerbes A, Nishigori H, Lee YM, Frens M, Kasuya H, Bazzoli F, Hickel R, Lee HS, van Leeuwen JPTM, Mitchell C, Kadomatsu K, Atherton J, Chan F

MedEdPublish (2016) 10 巻頁： 64 2021年

S-1 Facilitates C-REV Induced Anti-Tumor Efficacy in Triple Negative Breast Cancer Model

Kasuya, H; Naoe, Y; Matsumura, S; Bustos, I; Eissa, I; Mohamed, A; Tanaka, M

MOLECULAR THERAPY 28 巻 ( 4 ) 頁： 163 - 163 2020年4月

Phase I study of the oncolytic viral immunotherapy agent canerpaturev (C-REV) with S-1 in patients with stage IV pancreatic cancer 国際誌

Hijioka, S; Ueno, M; Ioka, T; Hirooka, Y; Ohno, E; Okusaka, T; Maruki, Y; Kobayashi, S; Ashida, R; Yashika, J; Furuse, J; Ikeda, M; Kasuya, H; Tanaka, M; Hashimoto, Y

ANNALS OF ONCOLOGY 30 巻 2019年10月

Results from phase I study of the oncolytic viral immunotherapy agent Canerpaturev (C-REV) in combination with gemcitabine plus nab-paclitaxel as first-line treatment of unresectable pancreatic cancer 国際誌

Hashimoto, Y; Hijioka, S; Hirooka, Y; Ohno, E; Ioka, T; Kobayashi, S; Okusaka, T; Maruki, Y; Yashika, J; Ashida, R; Furuse, J; Ikeda, M; Kasuya, H; Tanaka, M; Ueno, M

ANNALS OF ONCOLOGY 30 巻頁： 269 - + 2019年10月

Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth 査読有り国際誌

Wu, ZW; Ichinose, T; Naoe, Y; Matsumura, S; Villalobos, IB; Eissa, IR; Yamada, S; Miyajima, N; Morimoto, D; Mukoyama, N; Nishikawa, Y; Koide, Y; Kodera, Y; Tanaka, M; Kasuya, H

MOLECULAR THERAPY-ONCOLYTICS 13 巻頁： 107 - 115 2019年6月

Joint Degree Program for Graduate Students at the Nagoya University Graduate School of Medicine 査読有り

Kasuya, H; Aleksic, B; Sumigama, S; Bustos, I; Hasegawa, H; Kasai, MP; Kobayashi, M; Samizo, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE 81 巻 ( 2 ) 頁： 183 - 192 2019年5月

STING is dispensable for low susceptibility for HF10 in pancreatic cell lines

Matsumura, S; Morimoto, D; Noe, Y; Ichinose, T; Tanaka, M; Kodera, Y; Kasuya, H

CANCER SCIENCE 109 巻頁： 1328 - 1328 2018年12月

　前のページ - 次のページ　

<粕谷 英樹>

論文 - 粕谷 英樹

<粕谷　英樹>

論文 - 粕谷　英樹